Added to YB: 2026-03-25
Pitch date: 2026-03-23
OMDA [neutral]
Omada Health, Inc.
+19.1%
current return
Author Info
EAA Partners shares insights and investment theses on global companies, driven by in-depth research and long-term conviction. Sign up for the newsletter.
Company Info
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States.
Market Cap
$942.3M
Pitch Price
$13.77
Price Target
N/A
Dividend
N/A
EV/EBITDA
-118.40
P/E
-45.48
EV/Sales
2.77
Sector
Health Care Providers and Services
Category
growth
Omada Health, Inc. - $OMDA
OMDA (deep dive): Virtual chronic care provider w/ 30 peer-reviewed studies, CDC recognition, 53% rev growth to $260M FY25, +$6M adj EBITDA (first profit yr), 71% Q4 gross margin, 128% NDR, 886K members (+55% YoY). 150K GLP-1 members tripled in 12mo, 0.8% weight regain vs 11-12% controls. FY26 guide $312-322M (22% growth) excludes prescribing/cholesterol launch. Bear case: 60% rev from 2 unnamed PBM/health plan partners (concentration risk), deceleration optic, GLP-1 margin pressure. Bull case: conservative guide culture (beat FY25 by $38M rev), moat stack (13yr evidence base, accreditations), $222M cash/zero debt, AI enrollment +24%. At 2.0x EV/fwd rev vs 4-6x peers, current price prices bear case; base/bull requires concentration stable + new programs contribute H2 26. Q1 26 results & 10-K concentration disclosure (Apr-May 26) = key catalysts.
Read full article (41 min)